Incyte | INCY - Marktkapitalisierung

Aktienkurs
98.56
Täglich Wechseln
0.79 0.81%
Monatlich
1.65%
Jährlich
67.11%
Q2 Prognose
94.89




Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Agenus USD 107M 16M 2025-12
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.57B 290M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Exelixis USD 12.68B 1.79B 2026-05
Gilead Sciences USD 167.39B 5.6B 2026-05
Incyte USD 21.73B 3B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
MacroGenics USD 102M 4M 2025-12
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Neurocrine Biosciences USD 13.44B 189M 2026-05
Novartis USD 232.75B 75B 2026-05
Pfizer USD 149.77B 4.04B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sarepta Therapeutics USD 2.16B 123M 2026-05
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
Vertex Pharmaceuticals USD 111.03B 2.55B 2026-05